67 results
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
14 Mar 24
Current report (foreign)
8:00am
information about IPA's future outlook, future plans and expenditures, the satisfaction of rights and performance of obligations under agreements to which
6-K
EX-10.1
IPA
ImmunoPrecise Antibodies Ltd
23 Feb 24
Current report (foreign)
5:29pm
by the Commission under the Securities Act. The Company has complied to the Commission's satisfaction with all requests of the Commission for additional … to Sell Shares. The right of the Company to deliver an Issuance Notice hereunder is subject to the satisfaction, on the date of delivery
424B5
IPA
ImmunoPrecise Antibodies Ltd
23 Feb 24
Prospectus supplement for primary offering
5:26pm
of the other securities described herein ("Units"), (v) subscription receipts that entitle the holder to receive upon satisfaction of certain release … to receive, upon satisfaction of certain release conditions and for no additional consideration, Equity Securities, Debt Securities, Warrants, Units
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
14 Dec 23
Current report (foreign)
8:38am
and expenditures, the satisfaction of rights and performance of obligations under agreements to which IPA is a party, product development, future revenue growth
424B5
IPA
ImmunoPrecise Antibodies Ltd
7 Dec 23
Prospectus supplement for primary offering
4:53pm
) subscription receipts that entitle the holder to receive upon satisfaction of certain release conditions, and for no additional consideration, Equity … with one or more other Securities. The Subscription Receipts will entitle holders thereof to receive, upon satisfaction of certain release conditions
6-K
EX-8.1
2z84gvs9 zd3i5b5bdah
6 Dec 23
Current report (foreign)
5:19pm
6-K
EX-99.1
b07qn4t2hungf
6 Dec 23
Immunoprecise Antibodies LTD. 6-K
7:57am
6-K
EX-99.1
cvg7gio
6 Dec 23
Immunoprecise Antibodies LTD. 6-K
6:01am
424B5
dvstgfh3ifk
5 Dec 23
Prospectus supplement for primary offering
4:02pm
6-K
EX-99.1
ofp77j s4
14 Sep 23
Current report (foreign)
8:02am
6-K
EX-10.1
moigs58rljcy70g8
15 Aug 23
Current report (foreign)
5:50pm
424B5
jfvcm7iqpx onf
15 Aug 23
Prospectus supplement for primary offering
5:47pm
F-3
EX-5.1
m629ar741p7
10 Jul 23
Shelf registration (foreign)
7:04pm
F-3
fla6q2g56ng
10 Jul 23
Shelf registration (foreign)
7:04pm
F-3
EX-4.3
ellgt m8yazfq
10 Jul 23
Shelf registration (foreign)
7:04pm
40-F
EX-99.1
36kpyd
10 Jul 23
Annual report (Canada)
4:32pm
40-F
EX-99.3
c0e435k z7z5s2
10 Jul 23
Annual report (Canada)
4:32pm
6-K
EX-99.1
0zwz isczh58xe2psudi
24 Apr 23
Current report (foreign)
10:01am
6-K
EX-99.1
31egh v77n9x9d0wl4
15 Dec 22
Current report (foreign)
8:00am
6-K
EX-99.1
g7hwhnjkj42n8qpa
14 Sep 22
Current report (foreign)
8:31am